Sigyn Therapeutics, Inc. financial data

Symbol
SIGY on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
9190 W Olympic Blvd # 263, Beverly Hills, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Reign Resources Corp (to 10/23/2020), Reign Sapphire Corp (to 5/12/2020)
Latest financial report
10-K - Q4 2024 - Apr 15, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.35 % -45.3%
Quick Ratio 1.25 % -25.7%
Debt-to-equity -108 % +5.26%
Return On Equity 83.1 % -38%
Return On Assets -1.04K % -8.58%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.61M shares +31.1%
Common Stock, Shares, Outstanding 1.61M shares +24.6%
Entity Public Float 3.61M USD +93.9%
Common Stock, Value, Issued 161 USD +24.8%
Weighted Average Number of Shares Outstanding, Basic 1.33M shares +21.1%
Weighted Average Number of Shares Outstanding, Diluted 1.33M shares +21.1%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 773K USD -3.12%
General and Administrative Expense 1.74M USD +5.32%
Operating Income (Loss) -2.52M USD -2.6%
Nonoperating Income (Expense) -821K USD +51.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.34M USD +19.4%
Net Income (Loss) Attributable to Parent -3.34M USD +19.4%
Earnings Per Share, Basic -2.51 USD/shares +33.4%
Earnings Per Share, Diluted -2.51 USD/shares +33.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 12.1K USD +3.88%
Inventory, Net 50K USD 0%
Other Assets, Current 9.1K USD -83.9%
Assets, Current 21.2K USD -82%
Property, Plant and Equipment, Net 9.69K USD -36.7%
Operating Lease, Right-of-Use Asset 112K USD -33.2%
Other Assets, Noncurrent 70.7K USD +241%
Assets 214K USD -33.6%
Accounts Payable, Current 612K USD +69.1%
Liabilities, Current 4.61M USD +27.9%
Operating Lease, Liability, Noncurrent 56.4K USD -55.4%
Liabilities 4.67M USD +25.1%
Retained Earnings (Accumulated Deficit) -14.7M USD -29.5%
Stockholders' Equity Attributable to Parent -4.46M USD -30.6%
Liabilities and Equity 214K USD -33.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -236K USD +58.1%
Net Cash Provided by (Used in) Financing Activities 257K USD -70.7%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 1.61M shares +24.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 21.1K USD -93.3%
Deferred Tax Assets, Valuation Allowance 3.96M USD +30.9%
Operating Lease, Liability 126K USD -32.6%
Depreciation 5.61K USD -16.9%
Lessee, Operating Lease, Liability, to be Paid 134K USD -36.6%
Operating Lease, Liability, Current 69.9K USD +14.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 54.2K USD -31.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 79.5K USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.38K USD -68.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 54.2K USD +0%
Deferred Tax Assets, Operating Loss Carryforwards 4.01M USD +31%
Preferred Stock, Shares Issued 1.15 shares
Preferred Stock, Shares Authorized 10M shares 0%
Operating Lease, Payments 19K USD +3%
Additional Paid in Capital 10.2M USD +28.9%
Preferred Stock, Shares Outstanding 1.15 shares
Amortization of Intangible Assets 2.1K USD -41.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%